These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34411990)

  • 41. From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.
    Rath T; Billmeier U; Waldner MJ; Atreya R; Neurath MF
    Arch Toxicol; 2015 Apr; 89(4):541-54. PubMed ID: 25632846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-6 and insulin resistance.
    Kim JH; Bachmann RA; Chen J
    Vitam Horm; 2009; 80():613-33. PubMed ID: 19251052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The biology and medical implications of interleukin-6.
    Tanaka T; Kishimoto T
    Cancer Immunol Res; 2014 Apr; 2(4):288-94. PubMed ID: 24764575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6
    Chehboun S; Labrecque-Carbonneau J; Pasquin S; Meliani Y; Meddah B; Ferlin W; Sharma M; Tormo A; Masson JF; Gauchat JF
    J Biol Chem; 2017 Apr; 292(16):6644-6656. PubMed ID: 28280243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
    Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
    Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy.
    Linnemann AK; Blumer J; Marasco MR; Battiola TJ; Umhoefer HM; Han JY; Lamming DW; Davis DB
    FASEB J; 2017 Sep; 31(9):4140-4152. PubMed ID: 28592636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of targeting IL-1 and IL-18 in inflammation.
    Braddock M; Quinn A; Canvin J
    Expert Opin Biol Ther; 2004 Jun; 4(6):847-60. PubMed ID: 15174967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.
    Senn JJ; Klover PJ; Nowak IA; Zimmers TA; Koniaris LG; Furlanetto RW; Mooney RA
    J Biol Chem; 2003 Apr; 278(16):13740-6. PubMed ID: 12560330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.
    Dittrich A; Khouri C; Sackett SD; Ehlting C; Böhmer O; Albrecht U; Bode JG; Trautwein C; Schaper F
    Hepatology; 2012 Jan; 55(1):256-66. PubMed ID: 21898505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of interleukin-17 leads to a modulated micro-environment and amelioration of mechanical hypersensitivity after peripheral nerve injury in mice.
    Day YJ; Liou JT; Lee CM; Lin YC; Mao CC; Chou AH; Liao CC; Lee HC
    Pain; 2014 Jul; 155(7):1293-1302. PubMed ID: 24721689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin (IL-6) Immunotherapy.
    Tanaka T; Narazaki M; Kishimoto T
    Cold Spring Harb Perspect Biol; 2018 Aug; 10(8):. PubMed ID: 28778870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low molecular weight hyaluronan mediated CD44 dependent induction of IL-6 and chemokines in human dermal fibroblasts potentiates innate immune response.
    Vistejnova L; Safrankova B; Nesporova K; Slavkovsky R; Hermannova M; Hosek P; Velebny V; Kubala L
    Cytokine; 2014 Dec; 70(2):97-103. PubMed ID: 25126764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice.
    Ruwanpura SM; McLeod L; Brooks GD; Bozinovski S; Vlahos R; Longano A; Bardin PG; Anderson GP; Jenkins BJ
    Respirology; 2014 Apr; 19(3):419-27. PubMed ID: 24506702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there a role for prostanoid-mediated inhibition of IL-6
    Durham GA; Palmer TM
    Biochem Soc Trans; 2019 Aug; 47(4):1143-1156. PubMed ID: 31341036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.
    Wojdasiewicz P; Poniatowski ŁA; Szukiewicz D
    Mediators Inflamm; 2014; 2014():561459. PubMed ID: 24876674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition.
    Garbers C; Aparicio-Siegmund S; Rose-John S
    Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.